EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inflammatory Milieu and Specific T-Cell Response Observed Three Months and One Year After SARS-CoV-2 Infection in Long COVID Subjects

Eleonora Cimini iD, Alessandra Vergori iD, Claudia Cimaglia iD, Eleonora Tartaglia iD, Stefania Notari iD, Francesca Colavita iD, Giulia Matusali iD, Ilaria Mastrorosa iD, Valentina Mazzotta iD, Pierangelo Chinello, Paola Mencarini iD, Maria Letizia Giancola iD und 10 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262110412 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Eleonora Cimini und 21 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, 00149 Rome, Italy. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, T-Lymphocytes, Inflammation. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health (Ricerca Corrente Linea 1, project 8.1 A.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long COVID (LC) is characterized by a wide range of symptoms, the causes of which remain unclear. We investigated associations between inflammatory and coagulation factors, adaptive immune response to SARS-CoV-2, and LC. We enrolled 196 unvaccinated individuals with SARS-CoV-2 (March–June 2020). Blood samples were collected at three (T3M) and twelve (T12M) months post infection. Plasma concentrations of coagulation factors (D-Dimer, E-Selectin, ICAM-1, VCAM-1) and inflammatory markers (IL-6, IL-8, TNF-α, IL-1β) were measured by ELISA, and SARS-CoV-2-specific T-cell response was assessed by Elispot. LC occurred in 66/196 patients (34%); 77.8% had been hospitalized. Respiratory symptoms were present in 54%, fatigue in 30%, and neuropsychological symptoms in 14%. At T3M, hospitalized patients exhibited higher levels of ICAM-1, VCAM-1, and IL-6, along with increased immunoreactivity. LC patients exhibited elevated IL-8 and TNF-α and enhanced immunoreactivity at T3M, though these differences were not observed at T12M. Inflammatory and coagulation markers were altered at three months after acute infection, with some changes persisting at one year, suggesting a long-term immunological impact of SARS-CoV-2 on the inflammatory response. A SARS-CoV-2-specific T-cell response was still detectable at T12M, albeit at a lower level than at T3M, suggesting the persistence of protective memory T-cells beyond the acute phase.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2T-LymphocytesInflammationHumansMaleFemaleMiddle AgedAgedAdultIntercellular Adhesion Molecule-1BiomarkersCytokinesInterleukin-6

Stichwörter der Autor:innen

SARS-CoV-2T-cell responsecoagulationcytokinesinflammationlong COVID

Substanzen

Intercellular Adhesion Molecule-1BiomarkersCytokinesInterleukin-6

Autor:innen und Institutionen

  • Laboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, 00149 Rome, Italy.
  • HIV/AIDS Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, 00149 Rome, Italy.
  • Epidemiology Unit, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, 00149 Rome, Italy.
  • Laboratory of Virology and Biosafety Laboratories, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, 00149 Rome, Italy.
  • Clinical Department, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, 00149 Rome, Italy.
  • Scientific Direction, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, 00149 Rome, Italy.

ORCID-Profile: Eleonora Cimini, Alessandra Vergori, Claudia Cimaglia, Eleonora Tartaglia, Stefania Notari, Francesca Colavita, Giulia Matusali, Ilaria Mastrorosa, Valentina Mazzotta, Paola Mencarini, Maria Letizia Giancola, Fabrizio Maggi, Pierluca Piselli, Enrico Girardi, Andrea Antinori, Marta Camici

Förderung

  • Italian Ministry of Health (Ricerca Corrente Linea 1
  • project 8.1 A

Zitieren

APA

Cimini, E., Vergori, A., Cimaglia, C., Tartaglia, E., Notari, S., Colavita, F., Matusali, G., Mastrorosa, I., Mazzotta, V., Chinello, P., Mencarini, P., Giancola, M. L., Abdeddaim, A., Casetti, R., Grassi, G., Gili, S., Cristofanelli, F., Maggi, F., Piselli, P., …, & Camici, M. (2025). Inflammatory Milieu and Specific T-Cell Response Observed Three Months and One Year After SARS-CoV-2 Infection in Long COVID Subjects. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262110412

Vancouver

Cimini E, Vergori A, Cimaglia C, Tartaglia E, Notari S, Colavita F, et al. Inflammatory Milieu and Specific T-Cell Response Observed Three Months and One Year After SARS-CoV-2 Infection in Long COVID Subjects. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262110412

BibTeX
@article{Cimini2025,
  author = {Cimini, Eleonora and Vergori, Alessandra and Cimaglia, Claudia and Tartaglia, Eleonora and Notari, Stefania and Colavita, Francesca and Matusali, Giulia and Mastrorosa, Ilaria and Mazzotta, Valentina and Chinello, Pierangelo and Mencarini, Paola and Giancola, Maria Letizia and Abdeddaim, Amina and Casetti, Rita and Grassi, Germana and Gili, Simona and Cristofanelli, Flavia and Maggi, Fabrizio and Piselli, Pierluca and Girardi, Enrico and Antinori, Andrea and Camici, Marta},
  title = {Inflammatory Milieu and Specific T-Cell Response Observed Three Months and One Year After SARS-CoV-2 Infection in Long COVID Subjects},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262110412}
}
Kostenlos starten →